216 related articles for article (PubMed ID: 24934764)
1. Recent trends for novel options in experimental biological therapy of β-thalassemia.
Finotti A; Gambari R
Expert Opin Biol Ther; 2014 Oct; 14(10):1443-54. PubMed ID: 24934764
[TBL] [Abstract][Full Text] [Related]
2. Alternative options for DNA-based experimental therapy of β-thalassemia.
Gambari R
Expert Opin Biol Ther; 2012 Apr; 12(4):443-62. PubMed ID: 22413823
[TBL] [Abstract][Full Text] [Related]
3. Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.
Breda L; Rivella S; Zuccato C; Gambari R
Expert Rev Hematol; 2013 Jun; 6(3):255-64. PubMed ID: 23782080
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation patterns of β-globin cluster in β-thalassemia patients.
Bao X; Zuo Y; Chen D; Zhao C
Clin Epigenetics; 2020 Dec; 12(1):187. PubMed ID: 33272312
[TBL] [Abstract][Full Text] [Related]
6. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.
Zuccato C; Breda L; Salvatori F; Breveglieri G; Gardenghi S; Bianchi N; Brognara E; Lampronti I; Borgatti M; Rivella S; Gambari R
Ann Hematol; 2012 Aug; 91(8):1201-13. PubMed ID: 22460946
[TBL] [Abstract][Full Text] [Related]
7. [γ-Globin Inductive Therapy of β-thalassemia and Its Relationship with MicroRNA].
Li YY; Gu J; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):627-31. PubMed ID: 27151042
[TBL] [Abstract][Full Text] [Related]
8. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches.
Sripichai O; Fucharoen S
Expert Rev Hematol; 2016 Dec; 9(12):1129-1137. PubMed ID: 27801605
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients.
Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S
PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Ali H; Khan F; Musharraf SG
Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
Cui S; Engel JD
Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
[TBL] [Abstract][Full Text] [Related]
12. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of γ-globin gene expression and its clinical applications].
Ju JY; Zhao Q
Yi Chuan; 2018 Jun; 40(6):429-444. PubMed ID: 29959116
[TBL] [Abstract][Full Text] [Related]
15. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters.
Breveglieri G; Salvatori F; Finotti A; Cosenza LC; Zuccato C; Bianchi N; Breda L; Rivella S; Bresciani A; Bisbocci M; Borgatti M; Gambari R
Anal Bioanal Chem; 2019 Nov; 411(29):7669-7680. PubMed ID: 31273412
[TBL] [Abstract][Full Text] [Related]
17. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.
Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW
Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297
[TBL] [Abstract][Full Text] [Related]
18. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
Thein SL
Adv Exp Med Biol; 2017; 1013():27-57. PubMed ID: 29127676
[TBL] [Abstract][Full Text] [Related]
19. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach.
Basak AN; Tuzmen S
Methods Mol Biol; 2011; 700():291-307. PubMed ID: 21204041
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Insights and Potential Modifiers as Therapeutic Targets in
Zakaria NA; Islam MA; Abdullah WZ; Bahar R; Mohamed Yusoff AA; Abdul Wahab R; Shamsuddin S; Johan MF
Biomolecules; 2021 May; 11(5):. PubMed ID: 34070036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]